Pseudomonas aeruginosa Exotoxin A is not essential for corneal disease severity or bacterial survival

This study demonstrates that despite being expressed in vivo, the type II-secreted Exotoxin A (ToxA) is not essential for bacterial survival, neutrophil recruitment, or disease severity in murine *Pseudomonas aeruginosa* keratitis, contradicting earlier findings that suggested a critical role for this toxin.

The Gist

The Big Picture: A Battle in the Eye

Imagine your eye is a fortress (the cornea). Sometimes, a very tough invader called Pseudomonas aeruginosa tries to break in. This bacteria is like a highly trained special forces unit that carries a massive arsenal of weapons to destroy the fortress and survive.

For a long time, scientists believed that one specific weapon, called Exotoxin A (ToxA), was the "nuclear bomb" of this arsenal. They thought that without this specific toxin, the bacteria would be weak, easily defeated by the body's immune system, and wouldn't cause much damage.

This new study asks a simple question: "Is this 'nuclear bomb' actually necessary for the bacteria to win the battle in the eye?"

The Experiment: Taking Away the Weapon

The researchers decided to test this theory by building a version of the bacteria that couldn't make the Exotoxin A weapon. They created three groups of "soldiers" to test in mice:

1. The Standard Army: Normal bacteria with all their weapons, including Exotoxin A.
2. The Disarmed Army: Bacteria where the gene for Exotoxin A was deleted (they can't make the weapon).
3. The Re-armed Army: The disarmed bacteria that had the gene put back in (to prove the deletion was the only thing causing changes).

They infected the eyes of mice with these groups and watched what happened over 24 to 48 hours.

The Findings: The "Nuclear Bomb" Wasn't Needed

The results were surprising and went against what everyone thought for the last 20 years.

• The Weapon Was Fired: First, they confirmed that the normal bacteria did fire the Exotoxin A weapon inside the mouse eye. So, the bacteria were trying to use it.
• No Difference in Damage: When they looked at the eyes, the "Disarmed Army" (without the toxin) caused just as much damage as the "Standard Army." The eyes were just as cloudy, and the infection was just as severe.
• No Difference in Survival: The bacteria without the toxin didn't die off faster. They survived and multiplied just as well as the ones with the toxin.
• No Difference in the Defense: The body's immune system (the "police force" of the eye, made of white blood cells) showed up in the same numbers and fought the same way, regardless of whether the bacteria had the toxin or not.

Even when the researchers tried to make the bacteria "weaker" by removing other major weapons (called Type III secretion systems), the lack of Exotoxin A still didn't make the bacteria any less dangerous.

Why the Confusion? (The "Species" Problem)

So, why did an earlier famous study say Exotoxin A was critical? The authors suggest a few reasons, using a helpful analogy:

The "Human vs. Mouse" Mismatch
Think of the immune system like a security system.

• In Humans: The security system has a specific sensor (called NLRP1) that detects when Exotoxin A is attacking. When it detects the toxin, it triggers a massive, chaotic alarm that causes a lot of tissue damage.
• In Mice: The security system is slightly different. It doesn't have that specific sensor for this toxin. The mouse immune system just doesn't "hear" the alarm the same way humans do.

Because the researchers used mice, they might have missed the damage that Exotoxin A causes in humans. The toxin might be a major villain in human eye infections, but in mice, the bacteria can win the war using its other weapons (like the Type III secretion system) without needing the "nuclear bomb."

The Takeaway

This paper is like a reality check for scientists. It tells us that:

1. Context matters: Just because a bacteria has a powerful weapon doesn't mean it needs that specific weapon to win in every situation.
2. Animal models have limits: What happens in a mouse eye might not perfectly match what happens in a human eye.
3. The bacteria are adaptable: Pseudomonas aeruginosa is so good at causing eye infections that it can win even if you take away one of its most famous toxins.

In short: The bacteria still caused a terrible eye infection even without Exotoxin A. This suggests that while the toxin might be important in humans, it isn't the single "make-or-break" factor scientists previously believed it to be in this specific type of infection.

Technical Summary

1. Problem Statement

• Context: Pseudomonas aeruginosa is a leading cause of bacterial keratitis, a vision-threatening corneal infection. While the Type III Secretion System (T3SS) and its effectors (ExoU, ExoS, ExoT, ExoY) are well-established drivers of disease severity, the role of the Type II Secretion System (T2SS) toxin, Exotoxin A (ToxA), remains controversial.
• The Conflict: A foundational study by Pillar and Hobden (2003) established that ToxA is critical for bacterial persistence and disease progression in murine keratitis models, suggesting that $\Delta$toxA mutants are rapidly cleared and cause reduced pathology. This view has dominated the field for two decades.
• The Gap: Despite the prevalence of ToxA in clinical isolates and its known mechanism (ADP-ribosylation of eEF-2 to halt protein synthesis), recent data suggests T3SS activity may dominate corneal pathology. The authors sought to re-evaluate the necessity of ToxA in a modern, rigorously controlled murine model, specifically addressing whether ToxA contributes to disease when T3SS is active or when T3SS activity is reduced.

2. Methodology

The study employed a comprehensive in vivo murine keratitis model combined with molecular and immunological techniques:

• Bacterial Strains:
  • Parental: P. aeruginosa PAO1F (an ExoS-expressing strain).
  • Mutants: An in-frame deletion of toxA ($\Delta$toxA) generated via allelic exchange in PAO1F.
  • Complemented Strains: $\Delta$toxA strains with toxA restored via chromosomal integration (mini-Tn7 system).
  • T3SS-Modulated Strains: Experiments were repeated in a "T3SS-low" PAO1 background and a $\Delta$pscD strain (T3SS-defective) to determine if T3SS activity masked ToxA's role.
• Infection Model:
  • C57BL/6 mice (6–12 weeks) underwent corneal epithelial abrasion followed by topical application of ~1 $\times$ 10$^6$ CFU of bacteria.
  • Infections were monitored at 24 and 48 hours post-infection (hpi).
• Assessment Techniques:
  • Expression Analysis: A toxA promoter-GFP reporter strain was used to visualize ToxA induction in vivo. Immunoprecipitation and Western blotting of corneal lysates confirmed ToxA protein presence.
  • Disease Severity: Quantified via brightfield microscopy (corneal opacity) and fluorescence imaging (bacterial load via GFP/RFP).
  • Bacterial Survival: Colony Forming Units (CFU) were enumerated from homogenized corneas.
  • Immune Response: Flow cytometry was used to quantify neutrophil (Ly6G$^+$) and monocyte (Ly6C$^+$, CCR2$^+$) infiltration at 24 and 48 hpi.
• Controls: All experiments included wild-type PAO1F, $\Delta$toxA, and complemented strains to ensure isogenic comparisons.

3. Key Contributions

• Re-evaluation of ToxA: The study challenges the long-held dogma that ToxA is essential for P. aeruginosa keratitis severity in mice.
• Validation of Expression: Confirmed that ToxA is indeed expressed and secreted in vivo during corneal infection, ruling out the possibility that the lack of phenotype was due to a failure of the toxin to be produced in the host environment.
• T3SS Independence: Demonstrated that even in backgrounds with reduced or absent T3SS activity (where ToxA might theoretically play a larger compensatory role), the deletion of toxA did not alter disease outcomes.
• Species-Specific Mechanism Hypothesis: Proposed a mechanistic explanation for the discrepancy between murine and human data, focusing on species-specific differences in NLRP1 inflammasome activation.

4. Results

• ToxA is Expressed In Vivo:
  • The toxA promoter reporter strain showed increased GFP fluorescence at 24 and 48 hpi.
  • Immunoblotting of corneal lysates confirmed the presence of ToxA protein in wild-type and complemented strains, but not in $\Delta$toxA mutants.
• No Impact on Bacterial Survival or Disease Severity:
  • CFU Counts: No significant difference in bacterial burden was observed between PAO1F, $\Delta$toxA, and complemented strains at 24 or 48 hpi.
  • Corneal Opacity: Brightfield imaging and opacity quantification revealed no significant difference in disease severity between the groups.
  • Fluorescence: Bacterial load visualized via fluorescence was consistent across all strains.
• No Impact on Host Inflammation:
  • Flow cytometry showed that neutrophil and monocyte recruitment was not significantly altered by the absence of ToxA.
  • The proportion of inflammatory monocytes (CCR2$^+$) remained consistent across groups.
• T3SS-Reduced Backgrounds:
  • In T3SS-low and $\Delta$pscD strains, the deletion of toxA still resulted in no discernible difference in corneal opacity, bacterial growth, or GFP signal compared to their respective wild-type controls.

5. Significance and Discussion

• Contradiction of Prior Literature: The findings directly contradict the Pillar and Hobden study, which reported that $\Delta$toxA mutants were cleared rapidly and caused milder disease. The authors note that despite matching inoculum, scarification methods, and bacterial growth conditions, their results differ, suggesting strain-specific or subtle environmental factors may influence ToxA's role.
• Dominance of T3SS: The data suggests that in the presence of active T3SS effectors (specifically ExoS in the PAO1 background), ToxA is redundant for driving corneal pathology. Even when T3SS is dampened, ToxA does not become a primary driver of disease.
• Species-Specific Inflammasome Activation (The "Human vs. Mouse" Gap):
  • The authors propose a critical mechanistic explanation for the discrepancy: ToxA targets eukaryotic elongation factor-2 (eEF-2), inducing ribotoxic stress.
  • In human cells, this stress activates the NLRP1 inflammasome via a ZAK$\alpha$-dependent pathway, leading to IL-1$\beta$ release and severe inflammation.
  • In murine cells, NLRP1B (the mouse ortholog) is activated primarily by proteolytic cleavage (e.g., by anthrax lethal factor) and does not respond to ribotoxic stressors like ToxA or anisomycin in the same way.
  • Conclusion: The lack of ToxA phenotype in mice may be due to the mouse cornea's inability to mount the specific NLRP1-dependent inflammatory response that ToxA triggers in human tissue.
• Clinical Implication: The study highlights the limitations of murine models for studying ToxA-mediated keratitis and underscores the necessity of using human-relevant models (e.g., human organoids or ex vivo human tissue) to fully understand the pathogenicity of ToxA in human infections.

Final Conclusion: Exotoxin A is expressed during P. aeruginosa keratitis but is not essential for bacterial persistence, neutrophil recruitment, or disease severity in the murine corneal infection model, likely due to species-specific differences in inflammasome signaling pathways.